The effect of cyclosporine on mortality and renal function in living related pediatric kidney transplant recipients

[1]  W. Savage,et al.  GYNAECOLOGISTS' ATTITUDES TO ABORTION , 1989, The Lancet.

[2]  G. Yee,et al.  Effect of age on cyclosporine pharmacokinetics in marrow transplant recipients. , 1987, Transplantation proceedings.

[3]  N. Yoshimura,et al.  PHARMACODYNAMIC ASSESSMENT OF THE IN VIVO CYCLOSPORINE EFFECT ON INTERLEUKIN‐2 PRODUCTION BY LYMPHOCYTES IN KIDNEY TRANSPLANT RECIPIENTS , 1985, Transplantation.

[4]  J. Najarian,et al.  Management and prevention of cyclosporine nephrotoxicity after renal transplantation: use of low doses of cyclosporine, azathioprine, and prednisone. , 1985, Transplantation proceedings.

[5]  P. Morris,et al.  Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine. , 1985, Transplantation proceedings.

[6]  S. Flechner,et al.  Use of cyclosporine in pediatric renal transplant recipients. , 1985, The Journal of pediatrics.

[7]  M. Winterborn.  Optimum treatment of end-stage renal failure. , 1983, Archives of disease in childhood.

[8]  G. Klintmalm,et al.  Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. , 1981, Surgery, gynecology & obstetrics.

[9]  G. Klintmalm,et al.  NEPHROTOXICITY OF CYCLOSPORIN A IN LIVER AND KIDNEY TRANSPLANT PATIENTS , 1981, The Lancet.

[10]  P. Morris,et al.  STUDIES ON THE IMMUNOSUPPRESSIVE PROPERTIES OF CYCLOSPORIN A IN RATS RECEIVING RENAL ALLOGRAFTS , 1980, Transplantation.

[11]  D. Dunn,et al.  CYCLOSPORIN A IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM CADAVER DONORS , 1978, The Lancet.

[12]  R. Calne,et al.  PROLONGED SURVIVAL OF PIG ORTHOTOPIC HEART GRAFTS TREATED WITH CYCLOSPORIN A , 1978, The Lancet.